Sintetica GmbH
Pharmaceutical Companies · Münster
Sintetica GmbH is a pharmaceutical company based in Münster, North Rhine-Westphalia, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Sintetica GmbH – Address & Contact
Sintetica GmbH Overview
Sintetica GmbH is a pharmaceutical company based in Münster, Nordrhein-Westfalen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as Sintetica GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
About Sintetica GmbH
Arzneiwithtel for Anästhesie, Intensivmedizin, Schmerztherapie and intrathekale Therapie the chronischen Spastik. Top-quality Made in Switzerlofd. Dafor steht Sintetica.
Location & Contact
Sintetica GmbH can be reached at the following address: Albersloher Weg 11, 48155 Münster – Phone: 02519159650. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Nordrhein-Westfalen or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as Sintetica GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Sintetica GmbH, based in Münster, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Nordrhein-Westfalen
Nordrhein-Westfalen is a significant pharmaceutical location in Germany. Companies such as Sintetica GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about Sintetica GmbH
What does Sintetica GmbH do?
Sintetica GmbH produces Medikamente einmal for den Bereich the Anästhesie & Schmerztherapie, with Schwerpunkt on the Regional- and Allgemeinanästhesie; zum antheen for Intensiv- and Notfallmedizin and for den Bereich the Neurologie, with Schwerpunkt on the Therapie the Spastik.
What medicines does Sintetica GmbH manufacture?
Sintetica GmbH is a pharmaceutical company in Münster. Einführung in Sintetica GmbH Sintetica GmbH is ein renommiertes company, the sich on the Erforschung, development and manufacturing of medicinesn spezialisiert hat. Mit Si Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Nordrhein-Westfalen
All Pharmaceutical Companies in Nordrhein-Westfalen on Sanoliste — or discover all categories by federal state.